Real-time enrollment status for this myasthenia gravis clinical trial
Current Status
Recruiting
Checked: October 12, 2026 at 3:22 PM UTC
| NCT Number | NCT04951622 |
| Recruiting Status | Recruiting |
| Condition | Myasthenia Gravis |
| Phase | PHASE3 |
| Target Enrollment | 199 participants |
| Active Locations | 24 sites in the US |
| Sponsor | Janssen Research & Development, LLC |
| Last Updated on CT.gov | July 27, 2026 (Jul 27, 2026) |
As of October 12, 2026: Clinical trial NCT04951622 is currently recruiting participants. This phase3 study for myasthenia gravis is actively seeking new participants at 24 locations across the United States. The study is sponsored by Janssen Research & Development, LLC. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT04951622 is actively recruiting participants as of October 12, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 24 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT04951622 was last updated Jul 27, 2026 (July 27, 2026). HelloStudys verifies this status automatically.